Patent foramen ovale may be causal for the first stroke but unrelated to subsequent ischemic events

Stroke

Volumn 42, Issue 10, 2011, Pages 2891-2895

  Mono, Marie Luise ^a   Geister, Laura ^a   Galimanis, Aekaterini ^a   Jung, Simon ^a   Praz, Fabien ^b   Arnold, Marcel ^a   Fischer, Urs ^a   Wolff, Stefan ^a   Findling, Oliver ^a   Windecker, Stephan ^b   Wahl, Andreas ^b   Meier, Bernhard ^b   Mattle, Heinrich P ^a   Nedeltchev, Krassen ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

cryptogenic stroke; patent foramen ovale; recurrence rate; right to left shunt

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL;

ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTERY DISEASE; ARTICLE; BLEEDING; BRAIN VASCULITIS; CRYPTOGENIC STROKE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATENT FORAMEN OVALE; PRIORITY JOURNAL; RECURRENT DISEASE; STROKE; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; ASPIRIN; BRAIN ISCHEMIA; FEMALE; FOLLOW-UP STUDIES; FORAMEN OVALE, PATENT; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RECURRENCE; STROKE; TICLOPIDINE; TREATMENT OUTCOME;

EID: 80053325685     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.619577     Document Type: Article

References (20)

1. Almekhlafi MA, Wilton SB, Rabi DM, Ghali WA, Lorenzetti DL, Hill MD. Recurrent cerebral ischemia in medically treated patent foramen ovale: A meta-analysis. Neurology. 2009;73:89-97.
2. Wahl A, Praz F, Findling O, Nedeltchev K, Schwerzmann M, Tai T, et al. Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment. Catheter Cardiovasc Interv. 2009;74: 124-129.
3. Paciaroni M, Agnelli G, Bertolini A, Pezzini A, Padovani A, Caso V, et al. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: The FORI (Foramen Ovale Registro Italiano) study. Cerebrovasc Dis. 2010;31: 109-116.
4. Becker M, Frings D, Schroder J, Ocklenburg C, Muhler E, Hoffmann R, et al. Impact of occluder device type on success of percutaneous closure of atrial septal defects - a medium-term follow-up study. J Interv Cardiol. 2009;22:503-510.
5. Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol. 2004;44:750-758. (Pubitemid 39099567)
6. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: Results of a who collaborative study. Bull World Health Organ. 1980;58:113-130. (Pubitemid 10013261)
7. Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. Toast. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24:35-41. (Pubitemid 23014379)
8. Pearson AC, Nagelhout D, Castello R, Gomez CR, Labovitz AJ. Atrial septal aneurysm and stroke: A transesophageal echocardiographic study. J Am Coll Cardiol. 1991;18:1223-1229.
9. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The gusto investigators. N Engl J Med. 1993;329:673-682.
10. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies. Neurology. 2000;55:1172-1179.
11. Furlan A MJ, Mauri L, Adams H, Albers G, Felberg R, Herrmann H, et al. Late breaking clinical trial and science abstracts from the american heart association's scientific session 2010; abstract 21752: CLOSURE I: A prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the Starflex septal closure system versus best medical therapy in patients with a stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Circulation. 2010;122:2218.
12. Mattle HP, Meier B, Nedeltchev K. Prevention of stroke in patients with patent foramen ovale. Int J Stroke. 2010;5:92-102.
13. Cramer SC, Rordorf G, Maki JH, Kramer LA, Grotta JC, Burgin WS, et al. Increased pelvic vein thrombi in cryptogenic stroke: Results of the paradoxical emboli from large veins in ischemic stroke (PELVIS) study. Stroke. 2004;35:46-50. (Pubitemid 38057588)
14. Kraywinkel K, Jauss M, Diener HC, Weimar C. Patent foramen ovale, atrial septum aneurysm, and stroke. An examination of the status of recent evidence. Nervenarzt. 2005;76:935-942. (Pubitemid 41187619)
15. Cabanes L, Mas JL, Cohen A, Amarenco P, Cabanes PA, Oubary P, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke. 1993;24:1865-1873. (Pubitemid 23352717)
16. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345:1740-1746.
17. Anzola GP, Zavarize P, Morandi E, Rozzini L, Parrinello G. Transcranial doppler and risk of recurrence in patients with stroke and patent foramen ovale. Eur J Neurol. 2003;10:129-135. (Pubitemid 36308206)
18. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: Patent foramen ovale in cryptogenic stroke study. Circulation. 2002;105: 2625-2631. (Pubitemid 34596039)
19. De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000;31:2407-2413.
20. Serena J, Marti-Fabregas J, Santamarina E, Rodriguez JJ, Perez-Ayuso MJ, Masjuan J, et al. Recurrent stroke and massive right-to-left shunt: Results from the prospective spanish multicenter (CODICIA) study. Stroke. 2008;39:3131-3136.